本頁面由Tiger Trade Technology Pte. Ltd.提供服務

NovoCure Limited

12.62
+0.45003.70%
盤後12.620.00000.00%19:09 EDT
成交量:160.32萬
成交額:2,004.60萬
市值:14.39億
市盈率:-10.33
高:12.73
開:12.24
低:12.13
收:12.17
52周最高:20.06
52周最低:9.82
股本:1.14億
流通股本:9,414.79萬
量比:1.44
換手率:1.70%
股息:- -
股息率:- -
每股收益(TTM):-1.2221
每股收益(LYR):-1.2221
淨資產收益率:-38.89%
總資產收益率:-9.06%
市淨率:4.23
市盈率(LYR):-10.33

資料載入中...

2025/10/30

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/10/30

重要事件披露

Form 8-K - Current report
2025/09/15

重要事件披露

Form 8-K - Current report
2025/08/28

重要事件披露

Form 8-K - Current report
2025/07/24

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/07/24

重要事件披露

Form 8-K - Current report
2025/07/01

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/07/01

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/07/01

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/07/01

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/06/30

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/06/30

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/06/30

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/06/06

重要事件披露

Form 8-K - Current report
2025/06/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/06/02

重要事件披露

Form 8-K - Current report
2025/05/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/04/24

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/04/24

重要事件披露

Form 8-K - Current report
2025/04/22

重要事件披露

Form 8-K - Current report